Resequencing of positional candidates identifies low frequency IL 23 R coding variants 1 protecting against inflammatory bowel disease . 2
نویسندگان
چکیده
protecting against inflammatory bowel disease. 2 Yukihide Momozawa, Myriam Mni, Kayo Nakamura, Wouter Coppieters, Sven Almer, Leila 3 Amininejad, Isabelle Cleynen, Jean-Frédéric Colombel, Peter de Rijk, Olivier Dewit, Yigael Finkel, 4 Miquel A. Gassull, Dirk Goossens, Debby Laukens, Marc Lémann, Cécile Libioulle, Colm 5 O'Morain, Catherine Reenaers, Paul Rutgeerts, Curt Tysk, Diana Zelenika, Mark Lathrop, 6 Jurgen Del-Favero, Jean-Pierre Hugot, Martine de Vos, Denis Franchimont , Severine Vermeire, 7 Edouard Louis & Michel Georges. 8 Unit of Animal Genomics, GIGA-R & Faculty of Veterinary Medicine, University of Liège (B34), 1 9 Avenue de l’Hôpital, 4000-Liège, Belgium. Division of Gastroenterology and Hepatology, IMK 10 Linköpings Universitet, Linköping, Sweden. Department of Gastroenterology, Erasme Hospital, ULB, 11 1070 Brussels, Belgium. Department of Pathophysiology, Gastroenterology Section, Catholic 12 University of Leuven, Leuven, Belgium. Registre EPIMAD, Hôpital Calmette, Lille, France. Applied 13
منابع مشابه
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which e...
متن کاملNovel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
This review identifies possible pharmacological targets for inflammatory bowel disease (IBD) within the IL-23/IL-17 axis. Specifically, there are several targets within the IL-23/IL-17 pathways for potential pharmacological intervention with antibodies or small molecule inhibitors. These targets include TL1A (tumor necrosis factor-like molecule), DR3 (death receptor 3), IL-23, IL-17 and the rec...
متن کاملCorrection: Pooled Sequencing of 531 Genes in Inflammatory Bowel Disease Identifies an Associated Rare Variant in BTNL2 and Implicates Other Immune Related Genes
The contribution of rare coding sequence variants to genetic susceptibility in complex disorders is an important but unresolved question. Most studies thus far have investigated a limited number of genes from regions which contain common disease associated variants. Here we investigate this in inflammatory bowel disease by sequencing the exons and proximal promoters of 531 genes selected from b...
متن کاملLow Frequency Variants in the Exons Only Encoding Isoform A of HNF1A Do Not Contribute to Susceptibility to Type 2 Diabetes
BACKGROUND There is considerable interest in the hypothesis that low frequency, intermediate penetrance variants contribute to the proportion of Type 2 Diabetes (T2D) susceptibility not attributable to the common variants uncovered through genome-wide association approaches. Genes previously implicated in monogenic and multifactorial forms of diabetes are obvious candidates in this respect. In ...
متن کاملBiology of TH17 Lymphocytes, their Cytokines and Role in Disease
T lymphocytes that are involved in cellular mediated immunity include two types known as TCD8+ (Cytotoxic T lymphocytes) and TCD4+ (helper T lymphocytes). TCD4+ has four main subtypes, including TH1, TH2, TH17, and Treg Lymphocytes.TH17 lymphocytes play a role in defense against microbes that TH1 and TH2 lymphocytes have not the ability to respond to them. The most important cytokines, which ar...
متن کامل